BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 7, 2020
View Archived Issues
Polymerase kappa and drug resistance
Read More
Sphingolipids accumulate in neurodegeneration
Read More
Carbohydrate metabolism implicated in neuropathy
Read More
Merck & Co. presents data from RESTORE-IMI 2 phase III study of Recarbrio
Read More
TGen and HonorHealth initiate study of atovaquone plus azithromycin in COVID-19
Read More
Topline data shows multifactorial activity of AXA-1125 and AXA-1957 in NAFLD
Read More
Nimbus Lakshmi patents TYK2 inhibitors
Read More
First-in-human data presented for KA-2507
Read More
NiKang Therapeutics synthesizes new HIF-2alpha inhibitors
Read More
Merck & Co. identifies IDO1 inhibitors
Read More
Suven Life Sciences describes new muscarinic M1 receptor PAMs
Read More
New SERPINA1 modulators presented by Vertex Pharmaceuticals
Read More
EOS-100850 shows excellent tolerance and clinical benefit in refractory solid tumors
Read More
New mouse model of mild spinal muscular atrophy
Read More
Amgen reports topline data from phase III study of Otezla for mild to moderate plaque psoriasis
Read More
New phase III study evaluates lenzilumab in hospitalized patients with COVID-19
Read More
DongWha Pharm plans phase II evaluation of DW-2008 for COVID-19
Read More
HIF-1alpha stabilizer GB-004 well tolerated in multiple-dose phase I study
Read More
Lineage Cell Therapeutics updates phase I/IIa results with OpRegen for dry AMD
Read More
FDA approves Elyxyb for acute treatment of migraine with or without aura
Read More
Enanta reports topline phase II data on EDP-305 in primary biliary cholangitis
Read More
FDA approves Tabrecta for metastatic NSCLC with METex14
Read More
FDA clears new phase I study of NBTXR-3 activated by radiation therapy for pancreatic cancer
Read More
